Bosh sahifaABUS • NASDAQ
add
Arbutus Biopharma Corp
3,51 $
Seans yopilganidan keyin:(0,85%)+0,030
3,54 $
Yopilgan:22-noy, 19:22:39 (GMT-5) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
3,46 $
Kunlik diapazon
3,45 $ - 3,53 $
Yillik diapazon
1,79 $ - 4,72 $
Bozor kapitalizatsiyasi
665,12 mln USD
Oʻrtacha hajm
910,00 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,34 mln | -71,25% |
Joriy xarajat | 4,54 mln | -22,34% |
Sof foyda | -19,72 mln | 1,92% |
Sof foyda marjasi | -1,47 ming | -241,18% |
Har bir ulushga tushum | -0,14 | 15,57% |
EBITDA | -17,14 mln | 18,34% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 127,79 mln | -4,76% |
Jami aktivlari | 140,44 mln | -11,47% |
Jami passivlari | 33,55 mln | -14,64% |
Umumiy kapital | 106,89 mln | — |
Tarqatilgan aksiyalar | 189,49 mln | — |
Narxi/balansdagi bahosi | 6,18 | — |
Aktivlardan daromad | -29,07% | — |
Kapitaldan daromad | -35,87% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -19,72 mln | 1,92% |
Operatsiyalardan naqd pul | -20,74 mln | 4,81% |
Sarmoyadan naqd pul | -11,99 mln | -214,93% |
Moliyadan naqd pul | 1,78 mln | 5,59% |
Naqd pulning sof oʻzgarishi | -30,94 mln | -220,11% |
Boʻsh pul | -10,88 mln | 21,66% |
Haqida
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia
Tashkil etilgan
2007
Sayt
Xodimlar soni
73
